BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15049699)

  • 1. Improved energy coupling of human P-glycoprotein by the glycine 185 to valine mutation.
    Omote H; Figler RA; Polar MK; Al-Shawi MK
    Biochemistry; 2004 Apr; 43(13):3917-28. PubMed ID: 15049699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
    Ruth A; Stein WD; Rose E; Roninson IB
    Biochemistry; 2001 Apr; 40(14):4332-9. PubMed ID: 11284689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.
    Stein WD; Cardarelli C; Pastan I; Gottesman MM
    Mol Pharmacol; 1994 Apr; 45(4):763-72. PubMed ID: 7910372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2004 Sep; 43(38):12081-9. PubMed ID: 15379547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residue G346 in transmembrane segment six is involved in inter-domain communication in P-glycoprotein.
    Storm J; O'Mara ML; Crowley EH; Peall J; Tieleman DP; Kerr ID; Callaghan R
    Biochemistry; 2007 Sep; 46(35):9899-910. PubMed ID: 17696319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein.
    Al-Shawi MK; Polar MK; Omote H; Figler RA
    J Biol Chem; 2003 Dec; 278(52):52629-40. PubMed ID: 14551217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein.
    Taguchi Y; Kino K; Morishima M; Komano T; Kane SE; Ueda K
    Biochemistry; 1997 Jul; 36(29):8883-9. PubMed ID: 9220975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide binding to the multidrug resistance P-glycoprotein as studied by ESR spectroscopy.
    Delannoy S; Urbatsch IL; Tombline G; Senior AE; Vogel PD
    Biochemistry; 2005 Oct; 44(42):14010-9. PubMed ID: 16229490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the lactose permease of Escherichia coli that decreases conformational flexibility and increases protein stability.
    Smirnova IN; Kaback HR
    Biochemistry; 2003 Mar; 42(10):3025-31. PubMed ID: 12627968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2006 Oct; 399(2):351-9. PubMed ID: 16813563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2007 Aug; 46(32):9328-36. PubMed ID: 17636884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle.
    AƤnismaa P; Gatlik-Landwojtowicz E; Seelig A
    Biochemistry; 2008 Sep; 47(38):10197-207. PubMed ID: 18759452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-Dependent colchicine transport by human erythrocyte glutathione conjugate transporter.
    Awasthi S; Singhal SS; Pandya U; Gopal S; Zimniak P; Singh SV; Awasthi YC
    Toxicol Appl Pharmacol; 1999 Mar; 155(3):215-26. PubMed ID: 10079207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton donor in yeast pyruvate kinase: chemical and kinetic properties of the active site Thr 298 to Cys mutant.
    Susan-Resiga D; Nowak T
    Biochemistry; 2004 Dec; 43(48):15230-45. PubMed ID: 15568816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for altered ion transport in Saccharomyces cerevisiae overexpressing human MDR 1 protein.
    Fritz F; Howard EM; Hoffman MM; Roepe PD
    Biochemistry; 1999 Mar; 38(13):4214-26. PubMed ID: 10194338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of P-glycoprotein ATPase by analogues of tetramethylrosamine: coupling of drug binding at the "R" site to the ATP hydrolysis transition state.
    Tombline G; Donnelly DJ; Holt JJ; You Y; Ye M; Gannon MK; Nygren CL; Detty MR
    Biochemistry; 2006 Jul; 45(26):8034-47. PubMed ID: 16800628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interhelical packing modulates conformational flexibility in the lactose permease of Escherichia coli.
    Ermolova NV; Smirnova IN; Kasho VN; Kaback HR
    Biochemistry; 2005 May; 44(21):7669-77. PubMed ID: 15909981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of glycine 185 to valine alters the ATPase function of the human P-glycoprotein expressed in Sf9 cells.
    Rao US
    J Biol Chem; 1995 Mar; 270(12):6686-90. PubMed ID: 7896810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glycosylation and orientation in the membrane of the third cytoplasmic loop of human P-glycoprotein is affected by mutations and substrates.
    Loo TW; Clarke DM
    Biochemistry; 1999 Apr; 38(16):5124-9. PubMed ID: 10213617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
    Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG
    Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.